Microgranular acute promyelocytic leukemia: a proposed role for a greater deformability of the leukemic cell

G Cantin1, V Bernier, S Jacob

  • 1Centre d'Hématologie et d'Immunologie Clinique, Hôpital du Saint-Sacrement, Laval, Québec, Canada.

Nouvelle Revue Francaise D'Hematologie
|January 1, 1989
PubMed

Insights

This case study details a rapidly fatal microgranular acute promyelocytic leukemia (APL) in a child, presenting with disseminated intravascular coagulation. Researchers hypothesize microgranular promyelocytes

Area of Science:

  • Hematology
  • Oncology
  • Cell Biology

Background:

  • Acute promyelocytic leukemia (APL) is a subtype of acute myeloid leukemia.
  • The M-3 variant of APL is characterized by specific cytomorphologic features.
  • Understanding APL subtypes is crucial for diagnosis and treatment.

Observation:

  • A rare case of microgranular acute promyelocytic leukemia (APL), M-3 variant, in a 5-year-old boy.
  • The patient presented with rapidly fatal disseminated intravascular coagulation (DIC) and leukocytosis.
  • Distinct promyelocyte subtypes were identified based on cytoplasmic granulation: microgranular and characteristic large forms.

Findings:

  • A significant discrepancy in the ratio of microgranular to large promyelocytes was observed between bone marrow (1:1.2) and peripheral blood (1:4).
  • Hypothesis: Microgranular promyelocytes exhibit increased deformability compared to typical promyelocytes.
  • This cellular characteristic may facilitate marrow egress, contributing to hyperleukocytosis in the M-3 variant.

Implications:

  • The findings suggest a potential mechanism for hyperleukocytosis in APL M-3 variant.
  • Increased understanding of microgranular promyelocyte behavior may inform prognostic assessments.
  • Further research into APL cellular deformability could reveal novel therapeutic targets.